Currently, two vaccines - Covishield and covaxin - are being used in the ongoing vaccination campaign against Corona in India. A third vaccine may be added soon. This Russian vaccine is expected to be Sputnik V. Dr Reddy's Laboratory, a Hyderabad-based company in India, is conducting its trials and is expected to approach the drug regulator in March for emergency approval. This vaccine will be available in India for $ 10 (about Rs 730).
Of the 10 vaccines approved worldwide, Sputnik V as well as the vaccines of American companies Pfizer and Mordana have proved to be more than 90% effective. For this reason, the fight against Corona can be expected to be strengthened with the availability of the Russian vaccine in India. The Russian vaccine has been created by the Gamalaya Institute of Russia and funded by the Russian Direct Investment Fund (RDIF). RDIF is also doing the deal on this vaccine from around the world.
RDIF CEO Kirill Dmitriev said that the price of the Moderna and Pfizer vaccines, which currently prove more than 90% efficacy, is three times the price of Sputnik V. With this, the Russian vaccine is being tried to reach more and more countries all over the world. The good thing is that it can be stored at a temperature of 2 to 8 ° C which is readily available in the current supply chain. The Russian vaccine is composed of two adenovirus vectors. The company is currently in talks with British firm AstraZeneca on combined trials with its vaccine - CoveShield. The company claims that the effectiveness of the AstraZeneca vaccine will increase further.
India will have the most effective and affordable vaccine
If the Russian vaccine is successful in all trials and is approved in India, it will be the most effective vaccine in trials. The efficacy of the Covishield vaccine being used in India has been 70%, while the phase-3 trials of Covaxin have not been completed yet. Because of this, the situation regarding its effectiveness is not clear.
The government is getting one dose of Covshield for 200 rupees and one dose of Covaxin for 295 rupees. At the same time, CoviShield's dose in the market will be Rs 1,000. Covaxin has not yet disclosed the market price. In such a situation, Sputnik V priced at Rs 730 can be the cheapest and effective vaccine in the market.
Which countries have received approval so far
Dimitrev said Sputnik V has so far received approval in Russia, Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay, UAE, Turkmenistan. Hungary has become the first country in the European Union to approve it. Approval can be obtained soon from the Drug Regulator of the European Union.
YouTuber Elvish Yadav, who is always in controversies, is again in the news due to another scanda
Wrote ORIG to Orange, PON to Pawan, officers were stunned to see such English of the headmaster
These days there is a discussion of a Guru Ji in Bihar, who is in the headlines for his knowledge
Many cases of slow overrate are coming to the fore in IPL 2025. In the latest case, Rajasthan Roy
A few days after Sidhu Musewala was killed, a threatening letter was sent to Bollywood actor Salm
Private employees will now have to work 10 hours instead of 9, a rule implemented in this state
The Devendra Fadnavis government of Maharashtra on Wednesday increased the maximum working hours
The term of Reserve Bank of India (RBI) Governor Shaktikanta Das is ending today on 10 December 2
All the central unions including farmer organizations have called for Bharat Bandh across the cou
Hindu temple attacked in Canada, targeted for the third time by Khalistan supporters;
Once again news of an attack on a Hindu temple is coming to the fore in Canada. A Canadian journa
The farmers should be cleared the Sindhu border, the local people got down on the road and discuss
The deadlock over the new agricultural laws persists. Farmers have been standing on the Sindhu Bo
Immigration, Refugees and Citizenship Canada (IRCC) on Thursday said there will be a slowdown in
